AscellaHealth Releases Q3 2024 Specialty & Rare Pipeline Digest™: FDA-Approved Biosimilars Outpaces Cell and Gene Therapy Amid Complex Regulatory Challenges
22 oct. 2024 10h00 HE
|
AscellaHealth, LLC
BERWYN, Pa., Oct. 22, 2024 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, today released its latest...
AscellaHealth Announces its Strategic Acquisition of CHAPPER healthcare: Expands Global Specialty Pharmaceutical Wholesale and Product Distribution Services
17 oct. 2024 06h00 HE
|
AscellaHealth, LLC; CHAPPER healthcare
AscellaHealth Announces Strategic Acquisition of CHAPPER healthcare: Expands Global Specialty Pharmaceutical Wholesale and Product Distribution Services
Oncopeptides expands on WODA partnership with addition of Africa and Eurasia to provide Pepaxti to Patients
04 sept. 2024 08h00 HE
|
World Orphan Drug Alliance (WODA); Oncopeptides AB, Veld Pharmaceuticals GmbH, Slavpharma GmbH
Oncopeptides expands on WODA partnership with addition of Africa and Eurasia to provide Pepaxti to Patients
World Orphan Drug Alliance Expands to Japan & South Korea and the African Subcontinent
08 avr. 2024 07h30 HE
|
World Orphan Drug Alliance (WODA)
World Orphan Drug Alliance Expands to Japan & South Korea and the African Subcontinent
The North America Rare Disease Summit focused on the need for centralized data to improve the lives of 30 million people living with rare conditions
02 nov. 2023 15h51 HE
|
Bamberg Health
Stakeholders debate at the North America Rare Disease Summit on the challenges regarding treatment approvals and the importance of a proactive registry
Orphan Drugs market is projected to grow at a CAGR of 11.1% by 2033: Visiongain
05 oct. 2023 10h21 HE
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Orphan Drugs Market Report 2023-2033: Forecasts by Therapeutic Area (Cancer, Neurological Diseases, Cardiovascular Diseases, Hematologic Disorders,...
[Newly launched] Orphan Drugs Market is estimated to be US$ 869.6 billion by 2030 with a CAGR of 10.4% during the forecast period – By PMI
12 sept. 2023 13h30 HE
|
PMI
Covina , Sept. 12, 2023 (GLOBE NEWSWIRE) -- Introduction: Orphan drugs are used to treat and diagnose an orphan disease which can be serious or even cause life-threating. Orphan drugs are not...
Orphan Drugs Market to Experience Substantial Growth of 359.86 Billion by 2030, Size, Share, Trends, Demand, Opportunities, Growth Rate and Competitive Landscape
27 avr. 2023 17h30 HE
|
Data Bridge Market Research
Vancouver, April 27, 2023 (GLOBE NEWSWIRE) -- In its latest report, Data Bridge Market Research dissects growth strategies, drivers, opportunities, key segments, Porter's Five Forces analysis, and...
World Orphan Drug Alliance Expands to China, Israel, and Greece, Cyprus, and Malta
14 mars 2023 08h00 HE
|
World Orphan Drug Alliance (WODA)
Greater China region, Israel, and Greece, Cyprus and Malta are now also covered by the alliance. With the addition of three new WODA members - RareStone Group, CTS, and Path Pharma - WODA now provides...
Global Orphan Drugs Market Size – Forecasts to 2028
09 janv. 2023 09h00 HE
|
Global Market Estimates
Brooklyn, New York, Jan. 09, 2023 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the global orphan drugs market is expected to grow from USD...